Moderna announces Phase 3 trial results for mRNA-1283, its next-gen COVID-19 vaccine. A higher immune response was observed ...
Moderna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in ...
Pfizer and Moderna vaccines will likely be the first authorized in the U.S. Pfizer and Moderna are likely to be the first companies to see their respective vaccines authorized in the United States ...
The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 ... updated vaccines will be critical to protecting the population this season,” Moderna CEO Stéphane Bancel ...
A nurse shows the Moderna COVID-19 vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, Dec. 21, 2020. Eduardo Munoz/Reuters Regeneron is a drug cocktail consisting ...
Who may use the "Chart of the Day"? The Statista "Chart of the Day", made available under the Creative Commons License CC BY-ND 3.0, may be used and displayed without charge by all commercial and ...
Argentina's Health Ministry Carla Vizzotti insisted that people needed to get an additional shot of Covid ... vaccines developed and approved for use in humans are the adapted versions of Moderna ...
KUALA LUMPUR: Malaysia will receive 2.7 million doses of the new generation (bivalent) Covid-19 vaccines as a replacement for the almost expired stock that are being kept by the Health Ministry.
[Bert] decided to take a look at the mRNA source code of Tozinameran, the COVID-19 vaccine developed by BioNTech and Pfizer. The analysis is simple enough for the general reader, while nonetheless ...
DOZENS of patients at a surgery in Oxford have had their second Covid-19 vaccine delayed by weeks. There are now serious concerns over a hold-up of second doses of the Pfizer jab at the Botley ...
Logically, targeting intranasal (IN) vaccines to address a coronavirus makes a lot of sense, since coronaviruses are among a group of viruses implicated in e.g. the common cold. Like rhino- and ...